"Neuronal activity"-dependent transcriptional activation is required for the long-lasting, functional changes that are involved in memory consolidation or drug addiction. Elucidation of the molecular mechanisms underlying the neuronal activity-dependent transcription of synaptic plasticity-related genes has helped towards understanding neuronal function and disorders as well in identifying new target molecules for drug design. In this study, we focused on neurotrophin and neuropeptide, which both have the ability to modulate neuronal survival and function. We also examined the molecular mechanisms by which underlying neurotrophin genes are regulated by neuronal activity. Brain-derived neurotrophic factor (BDNF) is a neurotrophin family member that has important roles in neuronal survival and plasticity as well as in psychiatric disorders. Transcriptional activation of the BDNF gene is commonly regulated by a key transcription factor, cAMP response element-binding protein (CREB), and this at least in part contributes to neuronal activity-dependent neuronal survival. Among at least four distinct promoters of the BDNF gene, promoters I and III are differentially activated by Ca 2؉ signals via NMDA receptors and L-type voltage-dependent Ca 2؉ channels. Especially, BDNF gene promoter I activation requires the cooperative binding of and upstream stimulatory factor (USF) and CREB to a CRE/USF binding site. By contrast, NT-3 gene transcription is regulated by Sp3/4. An important future direction will be to elucidate how long-lasting changes in neuronal plasticity are "epigenetically" and "structurally" controlled. Our studies on the relationships between long-lasting neuronal responses and gene expressions should help guide research into novel drugs for neuronal or psychiatric disorders.
INTRODUCTION
Synaptic transmission plays an essential role in brain function. This specialized form of cellular communication acts not only as a signaling mechanism between neurons but also drives functional changes in neurons. At synapses, neurotransmitters are released from presynaptic terminals and act on receptors to activate a number of biochemical signaling cascades including cAMP, protein kinase A and mitogen-activated protein kinases (MAPKs), in postsynaptic spines of neurons. One of the most important processes is elevation of intracellular Ca 2ϩ : high frequency extra-cellular stimuli yields a highly efficient form of synaptic transmission that results in a long-lasting or a rapid influx of Ca 
. Environmental Stimuli Evoke High Frequency Synaptic Transmission and Synaptic Plasticity-Regulated Gene Expression
High frequency extracellular stimuli cause adaptive changes in the structure and function of neurons, leading to long-lasting functional changes in the brain. During this process, neurotransmitter receptor activation triggers a number of signal transductions pathways, of which the Ca 2ϩ signal is thought to be one of the most important signals carried to the nucleus because it affects expression of synaptic plasticity-regulated genes in neurons. In this review, we focused on the synaptic plasticity-regulated genes BDNF, NT-3 and PACAP genes to clarify their transcriptional and post-transcriptional mechanisms.
(MAPKs) cascades, Ca 2ϩ signals are finally transduced into the nucleus to regulate a variety of transcription factors and hence, gene expression. Activity-dependent gene expression is thought to be involved in the long-lasting changes in neuronal function that occur with drug addiction. Moreover, the processes of learning and memory are thought to be driven by synaptic plasticity, which is a remarkable feature of the brain (Fig. 1) . 1) Therefore, it is important to know how the Ca 2ϩ signal is transduced to the nucleus and which genes are regulated by these signals in neurons. Here I review our recent studies on the transcriptional regulation of the synaptic plasticity-regulated genes, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and pituitary adenylate cyclase activating polypeptide (PACAP), their physiological role in neurons and discuss future directions.
TRANSCRIPTION OF THE BDNF GENE
Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays a critical role in neuronal survival, differentiation and synaptic plasticity.
2) BDNF is predominantly expressed in the central nervous system, and its mRNA expression is up-regulated by neuronal activity that is accompanied by Ca 2ϩ influx into the postsynaptic spines of neurons. 3, 4) The BDNF gene consists of four 5Ј-non-coding exons (exons I, II III, IV) and a 3Ј-exon, exon V, that encodes the preproBDNF mRNA, giving rise to a total of eight transcripts (exons I-V, II-V, III-V and IV-V) (Fig. 2) . 5) Four promoters have been mapped upstream of exons I, II, III and IV, and these promoters are differentially activated by kainic acid-induced seizure in distinct regions of the rat brain.
5) The structure of the BDNF gene is complicated and the use of alternative promoters suggests that diversity and flexibility of BDNF gene expression is required for the fine-tuning of BDNF function. Therefore, it is very important to know how BDNF gene promoters are regulated and to understand the cellular mechanisms that control BDNF expression in neurons.
We performed reverse-transcription polymerase chain reaction (PCR) analysis to determine which of the BDNF gene promoters are activated by KCl-induced membrane depolarization. Transcripts containing exons I, II and III, except for exon IV, were up-regulated in rat cortical neurons (Fig. 4) . 6) In particular, transcripts pertaining to exons I-V and III-V were predominantly increased, therefore, we decided to analyze BDNF gene promoters I and III. In many cases, promoter analyses were performed in cell lines and not in primary cultured neurons because of the low efficiency of transfection. However, we designed the assay system for measuring the activity of calcium responsive promoters in rat cortical neurons.
We used a dual-luciferase reporter assay with two different kinds of luciferase reporter and internal control vectors derived from the firefly and Renilla. Next, we selected an internal control promoter (for example, thymine kinase (TK) or elongation factor 1a (EF1a) gene promoter) that is not responsible for calcium signals, and inserted it upstream of the Renilla gene. Finally, we used the calcium phosphate-precipitation method to transfect DNA into primary cultured cortical or hippocampal neurons. Using these methods we successfully measured calcium-responsive BDNF gene promoter activity in primary cultures of neurons (Fig. 5) . 7) Membranedepolarization caused by high concentrations of K ϩ (25 or 50 mM KCl) was effective in the induction of BDNF mRNA expression and activation of promoters I and III ( dependent Ca 2ϩ channels (L-VDCC), since 45 Ca 2ϩ influx was completely blocked by simultaneous administration of two Ca 2ϩ channel antagonists, nicardipine, an antagonist of L-VDCC, and DL-amino-5-phosphonovalerate (APV), an antagonist of NMDA receptors (Fig. 6A) . 8) Both BDNF gene promoters I and III were up-regulated by activation of these two Ca 2ϩ entry sites (Figs. 6B, C) . However, the two promoters responded differently to the two Ca 2ϩ channel antagonists (Figs. 6B, C) . BDNF promoter I activation was repressed by nicardipine, but not by APV, whereas promoter III activity The new arrangement of mouse and rat BDNF genes as described by Aid et al. 25) The authors analyzed DNA and mRNA sequence data using bioinformatics, 5ЈRACE and RT-PCR. The BDNF gene contains 5Ј-alternative non-coding exons and one protein coding exon. The three alternative splice donor sites within exon II, the alternative non-coding exons and two polyadenylation signals eventually give rise to twenty-two transcript species as shown in (C). Arrows indicate the sense primers that correspond to each of the 5Ј-non-coding exons and an antisense primer that corresponds to the 3Ј-coding exon. Rat cortical neurons (5 d in vitro) were stimulated with 25 mM KCl, and total RNA was isolated at the time indicated (0, 6, 12 h) and subjected to RT-PCR. The relative intensities of the amplified DNA fragments containing each exon were analyzed with an Image scanner and plotted. Cited from Tabuchi et al. 6) was partially blocked by nicardipine or APV alone, but completely blocked by their simultaneous administration. These findings indicate that activation of BDNF promoter I is sensitive to Ca 2ϩ entry via L-VDCC, whereas that of promoter III requires Ca 2ϩ entry via both L-VDCC and NMDA receptors. Differential usage of BDNF gene promoters in cortical neurons could be involved in controlling the multiple functions of BDNF in the mammalian nervous system.
Next, we tried to identify Ca 2ϩ -responsive DNA elements of BDNF promoter I and the transcription factors that bind to these responsive elements. Analysis of reporter activation with several mutants of BDNF promoter I revealed a requirement for two promoter regions in the transcriptional response to KCl-induced membrane depolarization (Fig. 7) .
6) Specifi- Ca 2ϩ uptake after treatment with Ca 2ϩ channel antagonists, 200 mM APV and/or 5 mM nicardipine. APV or nicardipine alone only partially inhibited Ca 2ϩ uptake. However, simultaneous addition of APV and nicardipine resulted in complete blockade of Ca 2ϩ uptake, indicating that 50 mM KCl-induced Ca 2ϩ uptake depends upon the activation of two Ca 2ϩ channels, NMDA receptors and L-VDCC. (B) and (C) show that activity of BDNF gene promoters I and III is affected by Ca 2ϩ channel antagonists, respectively. pϽ0.01 ( * * ), pϽ0.001 ( * * * ), and p is not significant (N.S.) with respect to the control without antagonists. Cited from Tabuchi et al. 8) cally, the proximal region from Ϫ107 to Ϫ65 was extremely effective in activation of BDNF promoter I. Thus, we focused on this region and investigated which DNA sequences within this region contribute to the activation. We found a cAMP response element (CRE) and upstream stimulatory factor (USF)-binding element (UBE) in this region that overlapped with each other. We found that CRE-binding protein (CREB) and USF bind to and activate BDNF promoter I at the CRE/UBE site (Fig. 8) .
Another Ca 2ϩ -responsive promoter, BDNF promoter III, has been characterized. BDNF promoter III contains three Ca 2ϩ -responsive elements (CaREs), CaRE1, CaRE2 and CaRE3. In addition to CREB, which specifically binds to CaRE3, USF binds to CaRE2 and thereby contributes to BDNF promoter III activation. [9] [10] [11] Furthermore, CaRF, a calcium response factor, binds to CaRE1 and activates transcription of BDNF exon III. 12) These findings suggest that CREB and other transcription factors cooperatively bind BDNF promoters I and III and that this could be a general mechanism for determination the specificity of gene expression in response to Ca 2ϩ signals (Fig. 8 ). As described above, we and other groups have reported that positive regulators control BDNF gene transcription. However, there are also a number of transcriptional repressors of BDNF expression. Neural restrictive silencer element/repressor element-1 (NRSE/RE-1) has been identified as a negative acting DNA element that inhibits the expression of neuronal genes in non-neuronal cell types and in neuronal subtypes. 13, 14) NRSE/RE-1 was found between exons I and II, in proximity to BDNF promoter II and this repressor had been shown to be functional in the brain. 15) These findings prompted us to study the silencing effect of NRSE/RE-1 on transcription of chimeric promoters in which NRSE is linked to upstream of BDNF promoter I and c-fos promoter. These chimeric promoters had a marked repressive effect in pri- Transcription factor CREB and USF bind to an overlapping sequence at the CRE/UBE site and promote transcription of exon I-containing BDNF transcripts. Promoter III is able to respond to Ca 2ϩ entry via L-VDCC and NMDA receptors. In addition to CREB and USF, a novel calcium responsive transcription factor, CaRF, coordinately promotes BDNF promoter III activity. mary glial cells but not in primary cortical neurons. 16) We wanted to identify the transcription factors that bind to NRSE/RE-1 by using the chimeric promoters of the BDNF or c-fos gene. Over-expression of the zinc finger transcription factor RE-1-silencing transcription factor (REST)/neuron-restrictive silencer factor (NRSF) 17, 18) resulted in repression of BDNF promoter I activity during KCl-stimulation. On the other hand, co-expression of REST4, which is a C-terminally truncated, neuronal-specific form of REST/NRSF, completely inhibited the silencing of BDNF promoter I by REST/NRSF. 19) Furthermore, Millecamps et al. reported that NRSE/RE-1 was used to target gene expression of vectors specifically to neuronal cells. 20) These findings indicate that linkage of NRSE to any promoter allows neuronal-specific expression of a gene of interest and avoids ectopic expression in non-neuronal cells. In other words, this NRSE strategy may be useful for gene therapy in the treatment of neurological disorders.
Another suppressor is Methyl-CpG-binding protein 2 (MeCP2), a member of the methyl-CpG-binding domain (MBD) family, which functions as a repressor that mediates silencing through binding to methylated CpG islands. 21) MeCP2 mutations are a cause of Rett syndrome (RTT), an Xlinked neurological disorder that leads to mental retardation in females. 22) Recently, MeCP2 has been reported as a regulator of BDNF gene transcription. Phosphorylation of MeCP2 at serine 421 is induced selectively in the brain and releases MeCP2 from BDNF promoter III, thereby activating transcription, dendritic arborization and maturation of dendritic spine morphology. 23, 24) Taken together, BDNF gene transcription plays an important role not only in neuronal function, but also in neurological disorders.
Notably, recent research into the BDNF gene has resulted in revision of the gene organization. Rat and mouse BDNF gene structures and expression are more complicated than initially reported. 25) Both mouse and rat BDNF genes consist of eight 5Ј non-coding exons (exon I, II, III, IV, V, VI, VII and VIII) and a common exon IX encoding a preproBDNF protein. It is thought that this combination of exons may give rise to twenty-two BDNF transcripts (Fig. 3 ) driven by nine promoters, which were mapped upstream of the nine 5Ј-exons. In this review, however, we refer to the previous structure of the rat BDNF gene, which consists of four 5Ј exons, a common exon V and four promoters (Fig. 2) . Therefore, exons I and III correspond to exons I and IV in the revised gene structure, respectively (Figs. 2, 3) . The human BDNF gene structure is more complex than that of the rodent one: it has eleven exons and nine functional promoters. Interestingly, in the human gene locus non-coding antisense RNAs are transcribed, suggesting that expression of BDNF gene in humans is incredibly complex. 26) TRANSCRIPTION OF THE NEUROTROPHIN-3 GENE Neurotrophin-3 is also a member of the neurotrophin family, which includes BDNF and neurotropin-4/5. [27] [28] [29] Despite several reports on the transcriptional regulation of the BDNF gene and the importance of NT-3 function, the molecular mechanisms that control NT-3 gene transcription are not fully understood. Therefore, we analyzed the responsiveness of NT-3 gene promoters to various stimuli. The NT-3 gene consists of at least two untranslated exons IA (EIA) and IB (EIB), and a common exon II, which codes for the preproNT-3 protein. 30) Promoters A and B are located upstream of EIA and EIB, respectively, resulting in expression of between two and six spliced variants in a variety of tissues. 31) We found an NT-3 transcript containing EIB that is predominantly expressed in cortical neurons, which preferentially utilize promoter B.
32) Two tandemly repeated GC-boxes, located between Ϫ100 and Ϫ60 base pairs within promoter B, are required for transcription of NT-3. Furthermore, we tried to investigate which transcription factors bind the NT-3 gene promoters and found that both specificity protein (Sp)3 and Sp4 bind to the Sp1 sequences within the GC boxes. Dominant negative Sp3 and Sp4 small interfering RNAs inhibited activation of NT-3 promoter B, suggesting that Sp3 and Sp4 contribute to NT-3 gene transcription (Fig. 9) . Sp4 knock out mice display a reduction of NT-3 mRNA expression, supporting our study. 33) Unlike the BDNF gene, NT-3 gene expression is not up-regulated by Ca 2ϩ entry via L-VDCC and NMDA receptors. Conversely, NT-3 mRNA expression was down-regulated by membrane depolarization-induced Ca 2ϩ entry in cerebellar granule cells. 34) Exclusive expression of the BDNF and NT-3 genes was also observed during cerebellar development. 35) However, these studies have not yet fully elucidated the signaling pathways or the transcription factors that are required for NT-3 promoter responsiveness to extracellular stimuli. Besides the NT-3 gene, a neuronal gene, p75 neurotrophin receptor, and the MeCP2 gene that is associated with Rett syndrome have also been identified as Sp1 familytarget genes. 37, 38) Sp1, Sp3 and Sp4 contain polyglutamine repeats and have been implicated in the pathogenesis of neurodegenerative diseases. 39, 40) Therefore, the identification of Sp transcription factor target genes such as NT-3 would help elucidate the molecular events involved, not only in nervous system development, but also in neurodegenerative disorders.
TRANSCRIPTION OF THE PACAP GENE
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a member of the vasoactive intestinal polypeptide/secretin/glucagon family. 41, 42) The PACAP gene consists of six exons including the coding region, such that three transcripts can be produced by differential usage of alternative exons 1A and 1B. In addition to the three previously reported transcripts, we found another novel PACAP transcript. 43) Like BDNF, PACAP gene transcription depends on neuronal activity that triggers Ca 2ϩ influx into neurons. 43 ) Thus, we investigated the Ca 2ϩ responsive DNA elements and the transcription factors which bind to these responsive elements. PACAP transcripts containing exons 1A or 1B were increased by membrane depolarization. Therefore, we fused the promoter region including exon 1A and 1B to a firefly luciferase reporter vector. Analysis of reporter activation with several kinds of PACAP promoter mutants revealed a requirement for only one region, CRE, in the transcriptional response to KCl-induced membrane depolarization (Fig. 10) . Activation of the PACAP promoter by KCl stimulation requires Ca 2ϩ influx via both L-VDCC and NMDA receptors (Fig. 10) .
44) The dependency of PACAP gene expression on Ca 2ϩ signals is similar to that of the BDNF gene. However, PACAP, but not the BDNF gene, also responded to cAMP signals. Treatment with forskolin, a cAMP inducer, and KCl caused a synergistic increase in PACAP promoter activity and mRNA levels. Furthermore, the half life of PACAP mRNA was longer when cortical neurons were treated with forskolin or KCl and mRNA stabilization was synergistically induced by addition of both forskolin and KCl. Although such an activity-dependent mRNA stabilization has not been reported, the mechanism might be explained by the presence of 5Ј-AU rich elements, located in the 3Ј-untranslated region of mRNA. 45) In this study, we demonstrated that the coordination of activity-dependent transcriptional activation and mRNA stabilization, which is mainly controlled by Ca 2ϩ and cAMP signals, plays an important role in acutely changing the cellular content of specific mRNA species in response to glutamatergic and dopaminergic inputs, possibly leading to the formation of long-lasting synaptic plasticity.
Recent studies have demonstrated that the process of drug addiction seems to be related to the neuronal plasticity associated with natural reward-related learning and memory. 46) In this process, the integration of two neurotransmitters, glutamate and dopamine appears to play a key role in the induction of intracellular transcriptional and translational cascades leading to adaptive changes in gene expression. Dopamine receptor 1 is a G-protein-coupled receptor (GPCR) that facilitates an increase in intracellular cAMP levels. Therefore, we speculate that the accumulation PACAP mRNAs evoked by Ca 2ϩ and cAMP signals might be regulated by activation of NMDA and dopamine receptors in vivo. Furthermore, PACAP or PACAP receptor KO mice display abnormal social behaviors as well as hyperactivity and impaired prepulse inhibition. [47] [48] [49] [50] Taken together, these findings suggest an important role for PACAP in emotion and behavior. Thus, analysis of the transcriptional mechanisms that control expression of the PACAP gene may, in part, contribute to our understanding of the pathogenesis of psychological disorders.
ACTIVITY-DEPENDENT NEURONAL SURVIVAL SUP-PORTED BY BDNF AND PACAP
Membrane depolarization evoked by elevating K ϩ concentrations is required for the survival of cerebellar granule cells (CGCs) and deprivation of membrane depolarization leads to apoptosis. This activity-dependent survival is mainly controlled by Ca 2ϩ influx into CGCs through L-VDCC. 51) BDNF, secretogranin-II (Sg-II) and parathyroid hormone related peptide (PTHrP) genes are up-regulated by membrane depolarization in CGCs. 52, 53) As described above, we found that expression of BDNF and PACAP genes is up-regulated by Ca 2ϩ entry and signalling. Furthermore, it has been reported that endogenous BDNF expression contributes to activity-dependent survival of cortical neurons. 54 ) Therefore, we investigated whether PACAP is endogenously synthesized and whether it contributes to activity-dependent survival of CGCs in culture. The expression of PACAP mRNA was induced in CGCs and protein levels were up-regulated by elevating KCl concentrations. However, a specific PACAP receptor antagonist, PACAP , prevented the attenuation of apoptosis of CGCs, but only partially. 55) These observations support the view that a specific interaction of secreted PACAP with PACAP receptors, contributes to the activity-dependent survival of CGCs. The partial inhibitory effect of PACAP on the attenuation of CGC apoptosis is probably due to the fact that membrane depolarization induces secretion of other proteins such as BDNF, PTHrP and VIP, which also enhance activity-dependent survival of CGCs. 34, 56) These findings strongly indicate a physiological role for neuronal plasticity-related gene such as BDNF and PACAP in activity-dependent survival (Fig. 11) .
CONCLUSION AND FUTURE DIRECTIONS
We focused on synaptic plasticity-related genes and elucidated several molecular mechanisms that underlie the regulation of neurotrophin genes by neuronal activity. We found that transcription factor CREB plays a crucial role in controlling BDNF and PACAP genes. However, it is still not clear how regulation of BDNF and PACAP gene expression is involved in the "long-lasting", functional changes in the brain.
Recently, maternal behavior toward offspring has been explained by epigenetic regulation or epigenetics and can affect "long-lasting" changes in the response of the offspring to stress throughout life. 57, 58) "Epigenetics" refers to the selfperpetuating, post-translational modifications of DNA and nuclear proteins that produce "long-lasting" changes in gene expression as an indirect consequence, such as DNA (Cytosine-5) methylation, histone acetylation-deacetylation and histone methylation-demethylation. Epigenetic modulation of the genome is thought to be a necessary component for longterm memory, 59, 60) therefore it would be worth trying to see if the BDNF gene is epigenetically regulated by DNA methyltransferases, histone acetyl transferases or by deacetylation during development, or in models of psychological disorders.
Another direction for future studies is how neuronal morphology is associated with gene expression. We are now focusing on actin-binding transcriptional coactivators and elucidating the mechanisms for its localization, transport from dendrites to the nucleus and transcriptional activation. 61, 62) "Epigenetics" appears to be different from "neuronal morphology" in terms of gene expression. However, the two themes have a common feature that is, "trace" within the structure. We will aim to elucidate the molecular mecha- nisms of signal transduction from the synapse to the nucleus and vice versa. We believe that our future studies will provide new insights into drug design and diagnostic reagents (Fig. 12) .
